BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20180662)

  • 1. Efficacy of opiate maintenance therapy and adjunctive interventions for opioid dependence with comorbid cocaine use disorders: A systematic review and meta-analysis of controlled clinical trials.
    Castells X; Kosten TR; Capellà D; Vidal X; Colom J; Casas M
    Am J Drug Alcohol Abuse; 2009; 35(5):339-49. PubMed ID: 20180662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methadone versus buprenorphine with contingency management or performance feedback for cocaine and opioid dependence.
    Schottenfeld RS; Chawarski MC; Pakes JR; Pantalon MV; Carroll KM; Kosten TR
    Am J Psychiatry; 2005 Feb; 162(2):340-9. PubMed ID: 15677600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desipramine in opioid-dependent cocaine abusers maintained on buprenorphine vs methadone.
    Oliveto AH; Feingold A; Schottenfeld R; Jatlow P; Kosten TR
    Arch Gen Psychiatry; 1999 Sep; 56(9):812-20. PubMed ID: 12884887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2002; (4):CD002207. PubMed ID: 12519569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effectiveness of opioid maintenance treatment in prison settings: a systematic review.
    Hedrich D; Alves P; Farrell M; Stöver H; Møller L; Mayet S
    Addiction; 2012 Mar; 107(3):501-17. PubMed ID: 21955033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2004; (3):CD002207. PubMed ID: 15266465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2003; (2):CD002207. PubMed ID: 12804429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
    Mattick RP; Kimber J; Breen C; Davoli M
    Cochrane Database Syst Rev; 2008 Apr; (2):CD002207. PubMed ID: 18425880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients.
    Kosten T; Oliveto A; Feingold A; Poling J; Sevarino K; McCance-Katz E; Stine S; Gonzalez G; Gonsai K
    Drug Alcohol Depend; 2003 Jun; 70(3):315-25. PubMed ID: 12757969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone maintenance at different dosages for opioid dependence.
    Faggiano F; Vigna-Taglianti F; Versino E; Lemma P
    Cochrane Database Syst Rev; 2003; (3):CD002208. PubMed ID: 12917925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heroin anticraving medications: a systematic review.
    Fareed A; Vayalapalli S; Casarella J; Amar R; Drexler K
    Am J Drug Alcohol Abuse; 2010 Nov; 36(6):332-41. PubMed ID: 20955107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contingency management for cocaine use in methadone maintenance patients: when does abstinence happen?
    Weinstock J; Rash CJ; Petry NM
    Psychol Addict Behav; 2010 Jun; 24(2):282-91. PubMed ID: 20565154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
    Heidebrecht F; MacLeod MB; Dawkins L
    Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multimodal drug addiction treatment: a field comparison of methadone and buprenorphine among heroin- and cocaine-dependent patients.
    Vigezzi P; Guglielmino L; Marzorati P; Silenzio R; De Chiara M; Corrado F; Cocchi L; Cozzolino E
    J Subst Abuse Treat; 2006 Jul; 31(1):3-7. PubMed ID: 16814005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine.
    Jordan CJ; Cao J; Newman AH; Xi ZX
    Neuropharmacology; 2019 Nov; 158():107609. PubMed ID: 31009632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of psychostimulant drugs for cocaine dependence.
    Castells X; Casas M; Pérez-Mañá C; Roncero C; Vidal X; Capellà D
    Cochrane Database Syst Rev; 2010 Feb; (2):CD007380. PubMed ID: 20166094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pills for speedballing or cocaine dependence.
    Johnson BA
    Lancet; 2006 May; 367(9524):1714-6. PubMed ID: 16731254
    [No Abstract]   [Full Text] [Related]  

  • 18. Promoting abstinence from cocaine and heroin with a methadone dose increase and a novel contingency.
    Epstein DH; Schmittner J; Umbricht A; Schroeder JR; Moolchan ET; Preston KL
    Drug Alcohol Depend; 2009 Apr; 101(1-2):92-100. PubMed ID: 19101098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of buprenorphine and methadone maintenance in opiate addicts.
    Eder H; Fischer G; Gombas W; Jagsch R; Stühlinger G; Kasper S
    Eur Addict Res; 1998; 4 Suppl 1():3-7. PubMed ID: 9767199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community reinforcement approach for combined opioid and cocaine dependence. Patterns of engagement in alternate activities.
    Schottenfeld RS; Pantalon MV; Chawarski MC; Pakes J
    J Subst Abuse Treat; 2000 Apr; 18(3):255-61. PubMed ID: 10742639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.